Drug Information

Drug General Information
Drug ID
D01RGG
Former ID
DNC006579
Drug Name
N-(4-tert-butylthiazol-2-yl)-1H-indol-4-amine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [528047]
Structure
Download
2D MOL

3D MOL
Formula
C15H17N3S
Canonical SMILES
CC(C)(C)C1=CSC(=N1)NC2=CC=CC3=C2C=CN3
InChI
1S/C15H17N3S/c1-15(2,3)13-9-19-14(18-13)17-12-6-4-5-11-10(12)7-8-16-11/h4-9,16H,1-3H3,(H,17,18)
InChIKey
ITGYBDHDFLFUCN-UHFFFAOYSA-N
PubChem Compound ID
21866574
Target and Pathway
Target(s) C-Cchemokine receptor type 4 Target Info Inhibitor [528047]
KEGG Pathway Cytokine-cytokine receptor interaction
Chemokine signaling pathway
Viral carcinogenesis
PANTHER Pathway Inflammation mediated by chemokine and cytokine signaling pathway
Reactome Chemokine receptors bind chemokines
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Peptide GPCRs
GPCR ligand binding
GPCR downstream signaling
References
Ref 528047Bioorg Med Chem Lett. 2006 May 15;16(10):2800-3. Epub 2006 Feb 23.Optimization of 2-aminothiazole derivatives as CCR4 antagonists.
Ref 528047Bioorg Med Chem Lett. 2006 May 15;16(10):2800-3. Epub 2006 Feb 23.Optimization of 2-aminothiazole derivatives as CCR4 antagonists.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.